Ultra-rapid progression of MAFLD to cirrhosis and post-transplant steatosis in a patient with a polygenic risk profile
MedScience · 2026-08 · 20 (4) · 739-743
DOI: 10.1007/s11684-026-1232-0 ↗Kurz gefasst
Fallbericht in der Zeitschrift MedScience, online erschienen am 18.09.2026. Verfasst von Zi-Ling Mai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, the First Affiliated Hospital of China Medical University, Shenyang, 110001, China. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Cirrhosis, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Metabolic dysfunction-associated fatty liver disease (MAFLD) usually progresses slowly, but some patients experience exceptionally rapid deterioration. We report a 38-year-old woman who progressed from biopsy-confirmed steatosis to decompensated cirrhosis within 11 months and developed recurrent graft steatosis 8 months after liver transplantation. Genetic testing revealed heterozygous variants in PNPLA3, TM6SF2, MBOAT7, and GCKR, indicating a polygenic predisposition to lipid accumulation, inflammation, and fibrogenesis. Histology and imaging analyses showed progressive steatosis with bridging fibrosis before transplantation and severe recurrence within the graft after transplantation, highlighting that transplantation does not eliminate the underlying metabolic-genetic vulnerability. This case suggests that a polygenic background may contribute to ultra-rapid disease trajectories and supports integrating genetic profiling into diagnostic and prognostic evaluation for MAFLD. Awareness of such risk patterns may guide early surveillance and long-term metabolic management even after transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, the First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
- Department of Gastroenterology, the First Affiliated Hospital of China Medical University, Shenyang, 110001, China. cb000216@163.com.
Zitieren
APA
Mai, Z. L., Chang, B., Li, Y. L., Wei, H., & Ma, B. T. (2026). Ultra-rapid progression of MAFLD to cirrhosis and post-transplant steatosis in a patient with a polygenic risk profile. MedScience, 20(4), 739-743. https://doi.org/10.1007/s11684-026-1232-0
Vancouver
Mai ZL, Chang B, Li YL, Wei H, Ma BT. Ultra-rapid progression of MAFLD to cirrhosis and post-transplant steatosis in a patient with a polygenic risk profile. MedScience. 2026;20(4):739-743. doi:10.1007/s11684-026-1232-0
BibTeX
@article{Mai2026,
author = {Mai, Zi-Ling and Chang, Bing and Li, Yi-Ling and Wei, Hong and Ma, Bo-Tong},
title = {Ultra-rapid progression of MAFLD to cirrhosis and post-transplant steatosis in a patient with a polygenic risk profile},
journal = {MedScience},
year = {2026},
volume = {20},
number = {4},
pages = {739--743},
doi = {10.1007/s11684-026-1232-0}
}
EUVIMED